Related by context. All words. (Click for frequent words.) 65 MEPACT 62 Yondelis ® 61 Cloretazine 61 histamine dihydrochloride 61 ANTEGREN 61 mifamurtide 60 ADVEXIN p# therapy 60 Genzyme Myozyme 60 Mepact 60 sunitinib malate 59 ARIXTRA R 59 BLP# Liposome Vaccine 59 YONDELIS 58 Teysuno 58 Li Fraumeni Syndrome 58 thetreatment 58 BrachySil TM 58 Ceflatonin R 58 YONDELIS R 58 PHX# 58 sorafenib Nexavar 58 epigenetic therapies 57 desvenlafaxine 57 Romiplostim 57 Aryplase 57 Removab 57 phase IIIb 57 Zemplar Capsules 57 Pertuzumab 57 Prospective Randomized 57 Accelerated Approval 57 GW# [003] 57 Temsirolimus 57 Degarelix 57 Phase 2b kidney transplant 57 PRIALT 57 Velcade bortezomib 57 PROMETA ® 57 immunotherapeutic vaccine 57 TEMODAL 57 pain palliation 57 oral ridaforolimus 57 Myocet 57 Cimzia TM 57 Phase IIB 57 ticagrelor Brilinta 57 TheraSphere R 57 Uvidem 57 Dyloject TM 56 Dacogen injection 56 novel oral anticoagulant 56 Orphan Status 56 trabectedin 56 Clolar ® 56 EVICEL 56 Quinamed 56 Voraxaze ™ 56 VALOR trial 56 IRESSA 56 NCCN Drugs 56 Zenvia ™ 56 inhalation powder 56 AFRS TM 56 Allovectin 7 56 Prosaptide 56 Pyridorin 56 cinacalcet 56 Fibrillex TM 56 Acthar Gel 56 SANVAR 56 preclinical efficacy 56 Onrigin 56 demethylating agent 56 Pixuvri 56 gefitinib Iressa 56 Perforomist ™ Inhalation Solution 56 neratinib 56 Neuradiab 56 Icatibant 56 Certican 56 Phase III multicenter 56 balsalazide tablet 55 SUTENT ® 55 Fully Covered Stent 55 lucinactant 55 APPRAISE 55 TRISENOX 55 RIGScan CR 55 Alvesco R 55 IV acetaminophen 55 nilotinib Tasigna 55 Vandetanib 55 phase IIb III 55 RH1 55 POSIDUR TM 55 thalidomide Thalomid 55 Ceflatonin 55 Dacogen decitabine 55 clevidipine 55 VTE prevention 55 Pfizer Camptosar 55 Noxafil 55 Phase IIb III 55 MGN# 55 Retacrit 55 PDE# inhibitors 55 Bezielle 55 CINTREDEKIN BESUDOTOX 55 NeuroSTAT ® 55 CINQUIL 55 SIR Spheres 55 bortezomib Velcade 55 NP2 Enkephalin 55 constipation OIC 55 Zarnestra 55 systemic immunosuppressive drugs 55 Fabry Disease 55 ZACTIMA 55 biliary tract cancer 55 inhaled AAT 55 ATIR 55 Camvia 55 ACCLAIM II 55 pemetrexed Alimta 55 HDL Selective Delipidation 55 Chemophase 55 Ambrisentan 54 KRN# 54 OvaRex 54 recurrent glioblastoma multiforme 54 Revlimid lenalidomide 54 Squalamine 54 Fondaparinux 54 IPLEX 54 Bayer HealthCare Onyx Pharmaceuticals 54 Tarceva TM 54 CVac 54 Vion Pharmaceuticals 54 PROCRIT R 54 Orphan Designation 54 Bellicum 54 ISTODAX 54 LUCASSIN 54 Vidaza azacitidine 54 Cintredekin besudotox 54 Xyrem ® 54 ADVEXIN therapy 54 CALGB # [002] 54 Civacir 54 Antisoma AS# 54 Glybera 54 Premarket Approval 54 Triapine 54 Biologic License Application BLA 54 Marketing Authorisation Application 54 MEND CABG II 54 AVASTIN 54 ospemifene 54 mechanical thrombectomy 54 Combidex 54 rhIGF-I/rhIGFBP-3 54 chemotherapeutic regimen 54 Voraxaze 54 anti angiogenic agents 54 Celgene Revlimid 54 NEUVENGE 54 MAGE A3 ASCI 54 antibody MAb 54 Omnitarg 54 Neurodex 54 genomic biomarker 54 Lenalidomide 54 Abatacept 54 ELIQUIS 54 Eluting Coronary Stent System 54 RSR# 54 haematological cancers 54 abatacept Orencia 54 Natroba 54 Neoadjuvant 54 TYGACIL 54 MAA submission 54 G#DT 54 FASLODEX 54 L BLP# 54 CONBRIZA 54 glufosfamide 54 BEXXAR 54 Numoda 54 Mipomersen 54 Medical Countermeasure 54 Ketotransdel 54 ZOLINZA 54 refractory chronic lymphocytic 54 non metastatic osteosarcoma 54 Firazyr 54 MGCD# clinical trials 54 PDE4 inhibitor 53 Azedra 53 Doribax 53 LEVADEX ™ 53 Myelodysplastic Syndromes MDS 53 relapsing multiple sclerosis 53 Alitretinoin 53 Huntexil 53 FDA APPROVES 53 Pazopanib 53 DrugLogic 53 Esbriet pirfenidone 53 cellular immunotherapy 53 Endovascular System 53 EP #R 53 vidofludimus 53 BLA filing 53 Estybon ™ 53 OvaDx 53 eprodisate Fibrillex TM 53 Bayer Onyx 53 LibiGel ® 53 IONSYS TM 53 Spiriva Handihaler 53 VIBEX MTX 53 Ceplene histamine dihydrochloride 53 Tracleer R 53 Guanilib 53 Xcytrin R 53 EGS# 53 Systemic Lupus Erythematosus SLE 53 NCCN guidelines 53 Telzir 53 intravenous methylnaltrexone 53 Kiacta 53 Spiegelmer ® 53 sorafenib tablets 53 Silodosin 53 gemcitabine Gemzar ® 53 Alferon N 53 hoFH 53 Viprinex TM 53 Trobalt 53 Zavesca R 53 Specifid 53 HuMax EGFr 53 Gendux 53 fludarabine cyclophosphamide 53 Ibritumomab Tiuxetan 53 bevacizumab Avastin 53 OncoGel 53 OPAXIO 53 temsirolimus 53 OHR/AVR# 53 Bayer Nexavar 53 Onco TCS 53 OvaRex MAb 53 MediQuest 53 CoFactor 53 Archexin 53 generation purine nucleoside 53 somatostatin analogues 53 Dabigatran 53 Tectin TM 53 Arranon 53 haematologic malignancies 53 Phase IIb clinical trials 53 alemtuzumab MS 53 NSABP B 53 Omalizumab 53 Pemetrexed 53 Ascend Therapeutics 53 Etanercept 53 Panzem R NCD 52 brivaracetam 52 Combunox 52 Vernakalant 52 Bevacizumab Avastin 52 Rasilamlo 52 AZILECT ® 52 ganaxolone 52 Glivec imatinib 52 Prestara TM 52 PHASE III 52 UroVysion 52 investigational therapies 52 Somatuline R Autogel R 52 personalized immunotherapy 52 oxypurinol 52 RX ACCULINK 52 dual endothelin receptor antagonist 52 Sanvar R 52 Zenpep 52 Desvenlafaxine 52 LymphoStat B TM 52 Trovax 52 SYGNIS 52 SUTENT 52 miglustat 52 ImmuKnow R 52 Afinitor everolimus 52 AVAX 52 IV Busulfex 52 MOTIVATE 52 Ixempra 52 Multiple Ascending Dose 52 Chronic lymphocytic leukemia 52 Cellegesic 52 TRANSDUR Bupivacaine 52 investigational immunotherapy 52 BeneFIX 52 OMS#HP 52 CoAxia 52 Raptiva R 52 Facet Solutions 52 PREOS 52 Wellstat 52 TORISEL TM 52 multiple myeloma MM 52 PMA submission 52 Zosano 52 Phase Ib study 52 immunodeficiency disorders 52 Surfaxin LS 52 Dacogen TM 52 Torisel 52 Gamunex C 52 ACUROX 52 Telatinib 52 Angiox 52 Darunavir 52 REVLIMID R 52 CRMD# 52 Nuvion 52 Nonclinical 52 Adaptive Radiation Therapy 52 SNS# T 52 PIX# trial 52 oral talactoferrin 52 FDA Approvable Letter 52 ularitide 52 aerosolized surfactant 52 Nexavar sorafenib 52 preclinical pharmacology 52 ZYBRESTAT fosbretabulin 52 SomatoKine 52 Endeavor DES 52 Omacetaxine 52 ruxolitinib 52 Myelodysplastic Syndromes 52 Catena ® 52 ACOMPLIA R 52 Panzem 52 liprotamase 52 Anturol TM 52 Amgen denosumab 52 antiangiogenic therapy 51 Enzyme Replacement Therapy 51 Adalimumab 51 Embolic Protection Device 51 Alemtuzumab 51 Liprostin 51 evaluating REVLIMID 51 Interferon beta 1a 51 Erythropoiesis Stimulating Agents ESAs 51 Avastin bevacizumab 51 pDNA vaccine 51 mRCC 51 Hycamtin 51 Plicera 51 Acute Coronary Syndromes ACS 51 agomelatine 51 relapsed refractory multiple myeloma 51 omacetaxine mepesuccinate 51 prasugrel Effient 51 Restanza 51 THALOMID R 51 wilate ® 51 pharmacogenetic testing 51 Biologics Compendium 51 OvaRex R 51 Toctino ® alitretinoin 51 torezolid phosphate 51 PhG alpha 1 51 treat chronic sinusitis 51 Preotact 51 MelaFind R 51 Revimmune TM 51 HQK 51 EECP ® therapy 51 OvaRex ® MAb 51 Candesartan 51 CAMPATH 51 REVEAL Registry 51 Zirgan 51 chronic idiopathic thrombocytopenic purpura 51 concurrent chemoradiation 51 Protelos 51 Bevacizumab 51 Hodgkin lymphoma HL 51 triphendiol 51 Brilique 51 QVAR ® 51 hESC derived RPE cells 51 ADAGIO study 51 Ozurdex 51 Solorel 51 Arzerra ofatumumab 51 Extina 51 DPX Survivac 51 Anavex #-# 51 Syllego system 51 Panzem ® 51 ZYBRESTAT TM 51 URG# 51 Phase IIIb clinical 51 Xerecept 51 PANVAC VF 51 TREDAPTIVE 51 SonoLysis 51 orphan designation 51 TheraSphere ® 51 Personalized Immunotherapy 51 Androxal TM 51 SEDASYS ® System 51 lomitapide 51 Gleevec resistant 51 Cardio Vascu Grow 51 zalutumumab 51 Cinacalcet HCl 51 Expression Genetics 51 IMC #B 51 nonhuman primate model 51 pertuzumab 51 optimal dosing regimens 51 Neovasc Reducer 51 XL# SAR# 51 Ataluren 51 external counterpulsation systems 51 refractory AML 51 Diasome 51 MabThera rituximab 51 immatics 51 DCCR 51 Vectibix panitumumab 51 sNDA filing 51 Everolimus 51 IGF 1R inhibitor 51 Evoltra ® 51 PF # [002] 51 eculizumab therapy 51 Tracleer r 51 immunotherapy treatments 51 Trofex 51 SNT MC# 51 Urocortin 2 51 mGlu2 3 51 Eraxis 51 r hGH 51 Benlysta belimumab 51 Xelox 51 Fingolimod 51 Radient Pharmaceutical current 51 EchoCRT 51 UVIDEM 51 Sandostatin LAR 51 Dendreon Provenge 51 Alimta pemetrexed 51 Mirapexin 51 Xcellerated T Cells 51 Saforis 51 aripiprazole Abilify 51 Taxotere ® 51 Omapro 51 ONCONASE R 51 Arno Therapeutics 50 QNEXA 50 Lucanix R 50 Novartis Afinitor 50 Randomized Evaluation 50 Hepatocellular Carcinoma HCC 50 European Medicines Evaluation 50 Sprycel dasatinib 50 tramiprosate Alzhemed TM 50 Mesafem 50 Somnus Therapeutics 50 Wyeth Torisel 50 RELOVAIR ™ 50 Medidur FA 50 TASKi3 50 romiplostim 50 lenalidomide Revlimid 50 adalimumab Humira 50 CA9 SCAN 50 CONTRAINDICATIONS 50 novel mTOR inhibitor 50 refractory CLL 50 regorafenib 50 dalbavancin 50 ReN# 50 OMAPRO ™ 50 Capesaris 50 Zometa zoledronic acid 50 Eplerenone 50 tipranavir 50 oral treprostinil 50 trastuzumab DM1 50 Torisel temsirolimus 50 Renal Cell Carcinoma RCC 50 Cancidas 50 CytoFab 50 IND submission 50 NeutroSpec 50 MAXY VII 50 REMINYL ® 50 Virulizin 50 Cordis Endovascular 50 DaTSCAN 50 Ixabepilone 50 Corlux 50 ViaCyte 50 HoFH 50 dexanabinol 50 enzastaurin 50 Betaferon R 50 FavId 50 edifoligide E2F Decoy 50 sNDA submission 50 Forsteo 50 confirmatory Phase III 50 Eli Lilly Cymbalta 50 Teva Provides Update 50 vaginally administered lidocaine 50 tramiprosate 50 OROS R Hydromorphone 50 cediranib 50 R roscovitine 50 Femara letrozole 50 recurrent NSCLC 50 Entocort 50 cartilage regeneration 50 ACTEMRA TM 50 Pfizer Sutent 50 VALSTAR 50 Aquinox 50 Phase Forward InForm 50 BrachySil ™ 50 Phase Ib clinical 50 Inc. NASDAQ NEOL 50 WILEX 50 azacitidine 50 Triapine R 50 PREOS R 50 TORISEL 50 Flutiform ™ 50 Axial Biotech 50 Fx #A 50 Tesmilifene 50 TroVax ® 50 Aurexis 50 idursulfase 50 Zelapar 50 Epirubicin 50 Targretin 50 Incara 50 urocortin 2 50 AERx iDMS 50 Vernalis plc 50 Sanvar 50 Rescula 50 rotigotine transdermal patch 50 CHMP recommendation 50 Arzerra TM 50 Altastaph 50 LensAR Laser System 50 CompuFlo 50 Idiopathic Pulmonary Fibrosis 50 Roche Xeloda 50 intravenous acetaminophen 50 Exelon Patch 50 GED aPC 50 TRIST study 50 oral PTH 50 Tovaxin TM 50 Multaq R 49 International Nonproprietary Name 49 Pimavanserin 49 ALVESCO R 49 ALARIS Medical Systems 49 OVATURE 49 Qscan 49 Zybrestat 49 NASDAQ INGN 49 MIST II 49 OraTest 49 Adlea TM 49 FIRAZYR 49 Product Monograph 49 metastatic malignant 49 Valortim TM 49 Multaq dronedarone 49 Abiraterone acetate 49 TARGIT 49 Sycrest 49 tasocitinib 49 GLP toxicology studies 49 Harry Palmin President 49 Order Optimizer 49 Rheos System 49 sodium oxybate oral 49 ponatinib 49 randomized Phase 2b 49 infliximab Remicade 49 Innovive 49 Rasagiline 49 Labguard ™ 49 GLIADEL R 49 DTIC 49 BENICAR 49 PharmaCom BioVet 49 octreotide implant 49 Vertex hepatitis C 49 AMPYRA ™ 49 Triolex 49 BLA submission 49 BRAF inhibitor 49 hypomethylating agents 49 GALNS 49 ZLB Behring 49 Myelodysplastic Syndrome MDS 49 Investigational Drugs 49 CIP TRAMADOL ER 49 SYN# 49 acute myeloid 49 Watson LIMS 49 Acute Heart Failure 49 Gammagard Liquid 49 MammoSite RTS 49 renoprotective 49 adult chronic ITP 49 Roche MabThera 49 Taxotere docetaxel 49 PROLASTIN C 49 faropenem 49 Cardica Microcutter XPRESS 49 hematological malignancy 49 CAPHOSOL 49 aerosolized KL4 surfactant 49 pharmacodynamic PD 49 Elestrin TM 49 RenalGuard System TM 49 tiapamil 49 RoACTEMRA 49 preclinical pharmacokinetic 49 PROCRIT ® 49 IIa trials 49 ablative therapy 49 Cutanea 49 BiDil XR 49 Accuray CyberKnife 49 follicular lymphoma FL 49 tocilizumab 49 PYY #-# 49 CIP ISOTRETINOIN 49 fibromyalgia syndrome 49 ProMune 49 BioZ ICG 49 RezularTM 49 KL4 surfactant 49 VIDAZA 49 Cimzia certolizumab pegol 49 Alseres 49 donepezil Aricept 49 recombinant factor VIIa 49 ACAPODENE 49 MelaFind ® 49 Arixtra ® 49 RETAANE R suspension 49 Gattex 49 AeroLEF TM 49 AstraZeneca Iressa 49 TH# [003] 49 predictive toxicology 49 STRIDE PD 49 Roche Actemra 49 Nesiritide 49 pancreatic islet cell 49 Phase #b/#a 49 NDA resubmission 49 Rasilez HCT 49 Bioral ® 49 Submits Investigational 49 Multiple Myeloma MM 49 Tocilizumab 49 Ralivia 49 anti arrhythmic 49 Poly ICLC 49 DiObex 49 Basilea Toctino R 49 NKI AVL 49 Telesso 49 efalizumab 49 Helsinn 49 AGHD 49 ENLIGHT 49 Myelofibrosis 48 Trandolapril 48 Memryte 48 AGGRASTAT ® 48 Complete Response 48 Zebinix R 48 lumiliximab 48 de novo AML 48 tezampanel NGX# 48 Davanat 48 Patient Registry 48 oxybutynin gel 48 pharmacologic therapies 48 SinuNase 48 Celator 48 Tasigna nilotinib 48 ASSERT 48 Ziprasidone 48 Arpida Ltd. 48 malignant pleural mesothelioma 48 RoActemra 48 Oncotype DX Recurrence Score 48 fenretinide 48 Acute Myeloid Leukemia 48 PRT# 48 cetilistat 48 PREVAIL 48 Boceprevir 48 P#X# antagonist 48 Fablyn 48 neovascular age 48 Cymbalta duloxetine HCl 48 Kynapid 48 Medifacts 48 temozolomide TMZ 48 Aquavan 48 Diabetic Foot Ulcer 48 Aquavan Injection 48 Cand5 48 asymptomatic hyperuricemia 48 monoclonal antibody therapeutics 48 Unither Pharmaceuticals 48 RPTP 48 celgosivir 48 chronic thromboembolic pulmonary 48 pioglitazone HCl 48 RUGs IV 48 Cardiometabolic 48 Glaxo Tykerb 48 reteplase 48 immunological diseases 48 FazaClo 48 cancer immunotherapies 48 PROSTVAC ® 48 Chimigen TM 48 Glatiramer acetate 48 CaPre TM 48 decitabine 48 Erbitux cetuximab 48 efficacy tolerability 48 gepirone ER 48 therapeutic regimens 48 dacetuzumab 48 BST CarGel R 48 phase IIb trial 48 adverse cytogenetics 48 Elocalcitol 48 INTRABEAM 48 MTWA testing 48 Eli Lilly Alimta 48 Hexvix 48 baminercept 48 Argatroban 48 postmarketing surveillance 48 MACUGEN 48 Tikvah Therapeutics 48 PEGylated interferon 48 Zelnorm Zelmac 48 BioSTAR ® 48 TAXOL 48 Cerepro 48 HCV protease inhibitors 48 Prestara 48 Nasdaq SGEN 48 Arimidex anastrozole 48 ruboxistaurin 48 MAXY G# 48 Sanofi Aventis Taxotere 48 MolecularMD 48 Tragara Pharmaceuticals Inc. 48 Exelon rivastigmine 48 Ception Therapeutics 48 Xeloda capecitabine 48 PRECISE 48 Metozolv ODT 48 Insulin PH# 48 MyoCath 48 SURFAXIN 48 Xillix 48 RevAssist 48 Gleevec imatinib mesylate 48 Clinical Guideline 48 lasofoxifene 48 INTERCEPT plasma 48 teriflunomide 48 Chronogen 48 Amorcyte 48 CardioFit 48 oral salmon calcitonin 48 Zelrix 48 prognostic indicators 48 Vimpat lacosamide 48 multicenter clinical trials 48 SPRIX ® 48 LEVAQUIN 48 Daxor 48 Metastatix 48 YM Biosciences 48 Gemcitabine 48 dorzolamide 48 IIa trial 48 NeuVax 48 Chemokine Therapeutics 48 TRIAS 48 DermTech International 48 ASCEND HF 48 TheraSphere 48 Vidaza 48 Sunesis Pharmaceuticals 48 OMP designation 48 oxymorphone ER 48 vandetanib 48 leukotriene receptor antagonists 48 antiangiogenic agent 48 RECOTHROM R 48 Egrifta 48 NUEDEXTA ™ 47 immunosuppressant therapies 47 anti CD# antibodies 47 Akela Pharma Inc. 47 Solorel ® 47 Adventrx 47 radiation dosimetry 47 somatostatin analog 47 granted Ortec 47 Xinlay 47 midstage clinical 47 eTag assays 47 GLPG# 47 QAB# 47 aclidinium bromide 47 leukemia AML 47 Myelodysplastic Syndromes Foundation 47 MEK inhibitor RDEA# 47 Frova ® 47 Telcyta 47 Jevtana 47 gastrointestinal stromal tumors 47 biomarker assay 47 VIAject R 47 WHO prequalification 47 bucindolol 47 Oncology Metrics 47 Votrient 47 Novartis Gleevec 47 pralatrexate injection 47 Cerashield 47 ILLUMINATE 47 Swissmedic 47 Pulminiq 47 NeoVista 47 Curon Medical 47 mTOR inhibition 47 smoldering myeloma 47 Toctino ® 47 platelet gel 47 Gendux AB 47 Telemonitoring 47 vinflunine 47 dabigatran etexilate 47 Endoscopic Ablation System 47 opioid analgesia 47 Akela Pharma 47 Trabectedin 47 PATHWAY 47 Mycophenolate mofetil 47 Optivia Biotechnology 47 oral anticoagulant therapy 47 FASTx TM 47 initiate Phase IIa 47 ENTOCORT EC 47 Proquin XR 47 transdermal patch formulation 47 pharmacological chaperone 47 Adva #a 47 Teflaro 47 Cimzia ® 47 BCX# 47 Lipid lowering 47 tolerability profiles 47 Reminyl galantamine 47 Chemoradiation 47 metastatic gastric 47 MyVax 47 MEND CABG 47 stratifying patients 47 transcranial Doppler ultrasound 47 Myelodysplastic Syndrome 47 AZOR 47 acute coronary syndromes ACS 47 Octreotide 47 Seikagaku 47 Emselex 47 FDA Advisory Panel 47 TOCOSOL Paclitaxel 47 MDS AML 47 pharmacoeconomic 47 Phase 1b dose escalation 47 Zavesca ® 47 Viventia Biotech 47 Ebixa 47 AVANDIA 47 HE4 test 47 Neupro R 47 Ore Pharmaceuticals 47 thorough QT 47 Neo Kidney Augment 47 eniluracil 47 molecular cytogenetic 47 VIAject 47 Theraputics 47 GRNVAC1 47 dirucotide MBP# 47 AtherOx 47 Clinical Trial Investigating REOLYSIN 47 NOVARTIS 47 AclarusDx ™ 47 rhLF 47 Exforge HCT 47 Solorel TM 47 myoblast therapy 47 Riluzole 47 FVIIa 47 Brachy 47 ColonSentry test 47 glucokinase activator 47 Salmedix 47 postapproval 47 Sorafenib 47 Phase 1b clinical trials 47 Talotrexin 47 ViRexx 47 hepatitis B vaccine Heplisav 47 Perforomist Inhalation Solution 47 ASCO GI 47 novel radiopharmaceuticals 47 cortical stimulation 47 collaborator Genentech 47 AutoloGel tm 47 Myelodysplastic syndrome 47 Nexeon MedSystems 47 Tarceva erlotinib 47 metastatic malignant melanoma 47 Centralised Procedure 47 Custom NX DES 47 CeNeS Pharmaceuticals plc 47 pancreatic adenocarcinoma 47 GENASIS 47 Migenix 47 Trofex TM 47 myeloproliferative 47 Keryx Biopharma 47 GIPET 47 Epiphany Biosciences 47 Powerlink System 47 Veronate 47 ProSavin 47 pharmacokinetic studies 47 cannabinor 46 Olaparib 46 oncological outcomes 46 TQT studies 46 Nexavar tablets 46 Nitec 46 Sequenom CMM 46 Aggrastat 46 Vaxfectin TM 46 Phase lll 46 BACcel 46 favorable pharmacokinetic profile 46 NASDAQ PCYC 46 LibiGel ® testosterone gel 46 AdreView 46 endothelin antagonist 46 VERSANT 46 Sutent sunitinib malate 46 Amyvid